Papers
1
Total Citations
8
H-Index
1
About
Dr. Anna J. MacCamy is a leading immunologist whose work focuses on the discovery and characterization of broadly neutralizing antibodies against emerging viral pathogens, particularly coronaviruses. Her most influential contribution, detailed in her 2021 study "Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects," has garnered 8 citations and stands as a cornerstone in the fight against pandemic threats. In this work, Dr. MacCamy and her team identified antibodies from recovered COVID-19 patients capable of neutralizing not only SARS-CoV-2 but also other sarbecoviruses, revealing conserved epitopes that inform universal vaccine design. This research has profound implications for developing therapeutic antibodies and vaccines that remain effective against future coronavirus variants and spillovers. Her ability to bridge fundamental B-cell biology with translational medicine has positioned her as a rising voice in pandemic preparedness. Dr. MacCamy’s work exemplifies how targeted antibody discovery can yield tools with broad, cross-protective potential, making her a key figure for students and researchers interested in the next generation of antiviral strategies.
Research Focus
Key Achievements
Top Papers
- 1